The management of anemia in patients with end-stage renal disease (ESRD) tr
eated with peritoneal dialysis (PD) has gained increasing attention over th
e past decade, similar to patients on hemodialysis (HD). However, there are
many differences between the 2 renal replacement therapies that pose uniqu
e challenges and solutions for monitoring, diagnosis and treatment of anemi
a in PD patients. These differences are not always evident and may be the r
esult of different patient selection, physical, emotional and motivational
factors, specific requirements of the modality or an indeterminate blend of
infinite gradations of all these factors. This review will highlight curre
nt issues in anemia management in PD patients.